$ALBT
Avalon Globocare Corp Stock $albt

$albt Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023024687 Filed on March 30, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$296.2K	$300.0K	$1.202M
YoY Change	-0.49%	-10.23%	-13.57%
Cost Of Revenue	$250.0K	$250.0K	$930.0K
YoY Change	14.44%	5.78%	-4.76%
Gross Profit	$47.72K	$40.00K	$272.7K
YoY Change	-39.73%	-59.12%	-34.21%
Gross Profit Margin	16.11%	13.33%	22.69%
Selling, General & Admin	$2.620M	$2.090M	$6.980M
YoY Change	25.39%	3.88%	2.22%
% of Gross Profit	5490.36%	5225.0%	2559.33%
Research & Development	$92.35K	$190.0K	$731.3K
YoY Change	-20.85%	-45.55%	-18.74%
% of Gross Profit	193.52%	475.0%	268.15%
Depreciation & Amortization	$61.06K	$80.00K	$330.7K
YoY Change	-28.15%	-5.9%	6.08%
% of Gross Profit	127.95%	200.0%	121.26%
Operating Expenses	$2.712M	$2.280M	$9.066M
YoY Change	22.93%	-3.42%	907.29%
Operating Profit	-$2.664M	-$2.240M	-$8.793M
YoY Change	25.26%	-1.02%	1711.18%
Interest Expense	$2.021K	-$150.0K	$176.0K
YoY Change	-103.84%	110.44%	-167.45%
% of Operating Profit
Other Income/Expense, Net	$36.55K	-$40.00K	-$11.93M
YoY Change	-66.47%	-200100.0%	-279510.94%
Pretax Income	-$2.784M	-$2.420M	-$11.93M
YoY Change	34.45%	3.67%	31.25%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$2.784M	-$2.420M	-$11.93M
YoY Change	34.45%	3.67%	31.25%
Net Earnings / Revenue	-939.99%	-806.67%	-992.44%
Basic Earnings Per Share	-$0.28		-$1.28
Diluted Earnings Per Share	-$0.28	-$0.25	-$1.28
COMMON SHARES
Basic Shares Outstanding	10.16M shares	99.22M shares	9.329M shares
Diluted Shares Outstanding	10.02M shares		9.329M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$890.0K	$1.990M	$1.990M
YoY Change	69.11%	146.43%	146.43%
Cash & Equivalents	$887.0K	$1.991M
Short-Term Investments
Other Short-Term Assets	$40.43K	$34.03K	$250.0K
YoY Change	-85.38%	-91.99%	-41.13%
Inventory
Prepaid Expenses		$248.0K
Receivables	$130.0K	$60.00K	$60.00K
Other Receivables	$0.00	$80.00K	$80.00K
Total Short-Term Assets	$1.391M	$2.374M	$2.370M
YoY Change	52.31%	79.4%	79.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$140.1K	$138.3K	$7.510M
YoY Change	-98.23%	-61.75%	-6.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$21.39M	$485.0K	$9.480M
YoY Change	4143.84%	-5.94%	1738.53%
Other Assets	$378.2K	$384.4K	$380.0K
YoY Change	113.86%	414.93%	85.63%
Total Long-Term Assets	$29.58M	$17.38M	$17.38M
YoY Change	237.87%	94.84%	94.86%
TOTAL ASSETS
Total Short-Term Assets	$1.391M	$2.374M	$2.370M
Total Long-Term Assets	$29.58M	$17.38M	$17.38M
Total Assets	$30.97M	$19.75M	$19.75M
YoY Change	220.34%	92.85%	92.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$102.0K	$100.0K	$1.220M
YoY Change	-94.85%		-26.95%
Accrued Expenses	$2.890M	$2.360M	$2.360M
YoY Change	-8.86%	0.86%	0.86%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.176M	$3.580M	$3.580M
YoY Change	0.56%	-18.67%	-18.67%
LONG-TERM LIABILITIES
Long-Term Debt	$5.340M	$4.560M	$4.560M
YoY Change	64.8%	65.8%	65.8%
Other Long-Term Liabilities	$550.0K	$450.0K	$450.0K
YoY Change		7527.12%	7527.12%
Total Long-Term Liabilities	$5.885M	$5.013M	$5.010M
YoY Change	81.63%	81.89%	81.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.176M	$3.580M	$3.580M
Total Long-Term Liabilities	$5.885M	$5.013M	$5.010M
Total Liabilities	$11.06M	$8.593M	$8.590M
YoY Change	31.88%	20.05%	20.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$65.85M	-$63.06M
YoY Change		23.33%
Common Stock	$66.48M	$65.95M
YoY Change		20.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$522.5K	$522.5K
YoY Change		0.0%
Treasury Stock Shares		52.00K shares
Shareholders Equity	$19.91M	$11.16M	$11.16M
YoY Change
Total Liabilities & Shareholders Equity	$30.97M	$19.75M	$19.75M
YoY Change	220.34%	92.85%	92.83%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.784M	-$2.420M	-$11.93M
YoY Change	34.45%	3.67%	31.25%
Depreciation, Depletion And Amortization	$61.06K	$80.00K	$330.7K
YoY Change	-28.15%	-5.9%	6.08%
Cash From Operating Activities	-$1.835M	-$1.970M	-$7.037M
YoY Change	258.92%	14.74%	40.06%
INVESTING ACTIVITIES
Capital Expenditures	$20.19K	$0.00	$1.749K
YoY Change	-1253.43%	-100.0%	-106.28%
Acquisitions
YoY Change
Other Investing Activities		-$9.000M	-$9.050M
YoY Change		7499900.0%	22356.58%
Cash From Investing Activities	-$20.19K	-$9.000M	-$9.053M
YoY Change	1053.43%	4999900.0%	13186.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$750.0K	9.000M	$17.26M
YoY Change	223.97%	351.85%	233.92%
NET CHANGE
Cash From Operating Activities	-$1.835M	-1.970M	-$7.037M
Cash From Investing Activities	-$20.19K	-9.000M	-$9.053M
Cash From Financing Activities	$750.0K	9.000M	$17.26M
Net Change In Cash	-$1.104M	-1.970M	$1.183M
YoY Change	292.2%	-817.28%	1426.73%
FREE CASH FLOW
Cash From Operating Activities	-$1.835M	-$1.970M	-$7.037M
Capital Expenditures	$20.19K	$0.00	$1.749K
Free Cash Flow	-$1.855M	-$1.970M	-$7.039M
YoY Change	264.11%	14.74%	40.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent		usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38728
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1685128
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	4400 Route 9 South
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 3100
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Freehold
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07728
CY2022	dei	City Area Code CityAreaCode	732
CY2022	dei	Local Phone Number LocalPhoneNumber	780-4400
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	ALBT
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	15433000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10164307	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum llp
CY2022	dei	Auditor Location AuditorLocation	New York
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1990910	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	807538	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	60526	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	33618	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	74100	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	33600	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	247990	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	448286	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	2373526	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1323042	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10885	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	145303	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	138294	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	361547	usd
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	7360087	usd
CY2021Q4	us-gaap	Real Estate Investments RealEstateInvestments	7528770	usd
CY2022Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	485008	usd
CY2021Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	515632	usd
CY2022Q4	avco	Advances For Equity Interest Purchase AdvancesForEquityInterestPurchase	8999722	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	384383	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	367922	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	17378379	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	8919174	usd
CY2022Q4	us-gaap	Assets Assets	19751905	usd
CY2021Q4	us-gaap	Assets Assets	10242216	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1673411	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1881349	usd
CY2022Q4	avco	Accrued Research And Developments Fees AccruedResearchAndDevelopmentsFees	838001	usd
CY2021Q4	avco	Accrued Research And Developments Fees AccruedResearchAndDevelopmentsFees	928111	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	223722	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	307043	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	450000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	283234	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	275320	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	100000	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	468433	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11437	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	151402	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	390000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3579805	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4401658	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5901	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	450000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4563152	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	2750262	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5013152	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2756163	usd
CY2022Q4	us-gaap	Liabilities Liabilities	8592957	usd
CY2021Q4	us-gaap	Liabilities Liabilities	7157821	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	9000000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10013576	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9961576	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8897518	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8845518	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1005	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	8898	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	65949723	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	54888559	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	52000	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	52000	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	522500	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	522500	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63062721	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51131874	usd
CY2022Q4	avco	Statutory Reserve StatutoryReserve	6578	usd
CY2021Q4	avco	Statutory Reserve StatutoryReserve	6578	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-213137	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-165266	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11158948	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3084395	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11158948	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3084395	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19751905	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10242216	usd
CY2022	us-gaap	Premiums Earned Net Property And Casualty PremiumsEarnedNetPropertyAndCasualty	1202169	usd
CY2021	us-gaap	Premiums Earned Net Property And Casualty PremiumsEarnedNetPropertyAndCasualty	1203560	usd
CY2021	avco	Medical Related Consulting Services Related Party MedicalRelatedConsultingServicesRelatedParty	187412	usd
CY2022	us-gaap	Revenues Revenues	1202169	usd
CY2021	us-gaap	Revenues Revenues	1390972	usd
CY2022	avco	Real Property Operating Expenses RealPropertyOperatingExpenses	929441	usd
CY2021	avco	Real Property Operating Expenses RealPropertyOperatingExpenses	829287	usd
CY2021	avco	Medical Related Consulting Services Related Parties MedicalRelatedConsultingServicesRelatedParties	147167	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	929441	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	976454	usd
CY2022	avco	Real Property Operating Income RealPropertyOperatingIncome	-272728	usd
CY2021	avco	Real Property Operating Income RealPropertyOperatingIncome	-374273	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.28
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.07
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9328609	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8491103	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	4116919	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2553409	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	202500	usd
CY2021	avco	Issuance Of Common Stock For Settlement Of Loan Payable Related Party IssuanceOfCommonStockForSettlementOfLoanPayableRelatedParty	3000000	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1507488	usd
CY2021	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	40245	usd
CY2022	us-gaap	Gross Profit GrossProfit	272728	usd
CY2021	us-gaap	Gross Profit GrossProfit	414518	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1325313	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	328565	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	2909652	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	4946696	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1863188	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2042278	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	731328	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1025009	usd
CY2022	avco	Loss From Lawsuit LossFromLawsuit	1350000	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	886142	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	905800	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	9065623	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	9248348	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-8792895	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-8833830	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3310684	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	185751	usd
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	79898	usd
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	200477	usd
CY2022	us-gaap	Other Expenses OtherExpenses	344264	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-41863	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-60463	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	600749	usd
CY2022	us-gaap	Other Income OtherIncome	223759	usd
CY2021	us-gaap	Other Income OtherIncome	4271	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3137952	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-256669	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11930847	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9090499	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11930847	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-9090499	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-11930847	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-9090499	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-11930847	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-9090499	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	47871	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-25244	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-11978718	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9065255	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11978718	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9065255	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	769334	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	25244	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-9090499	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3084395	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	362328	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	498509	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	4072958	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2181820	usd
CY2022	avco	Issuance Of Common Stock For Settlement Of Loan Payable And Accrued Interest Related Party IssuanceOfCommonStockForSettlementOfLoanPayableAndAccruedInterestRelatedParty	2888593	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	350000	usd
CY2022	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	9000000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	340950	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	358113	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-47871	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11930847	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11158948	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11930847	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-9090499	usd
CY2022	us-gaap	Provision For Other Losses ProvisionForOtherLosses	2295	usd
CY2021	us-gaap	Provision For Other Losses ProvisionForOtherLosses	8091	usd
CY2022	us-gaap	Depreciation Depreciation	330723	usd
CY2021	us-gaap	Depreciation Depreciation	311761	usd
CY2022	us-gaap	Straight Line Rent StraightLineRent	6821	usd
CY2021	us-gaap	Straight Line Rent StraightLineRent	51246	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	135557	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	127020	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1106634	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2110169	usd
CY2022	avco	Loss On Equity Method Investment LossOnEquityMethodInvestment	41863	usd
CY2021	avco	Loss On Equity Method Investment LossOnEquityMethodInvestment	60463	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-22285	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3281078	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	29606	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	344264	usd
CY2022	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	600749	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	3265	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	168	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	40500	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	33600	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-416	usd
CY2021	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	6847	usd
CY2022	avco	Deferred Leasing Costs DeferredLeasingCosts	27298	usd
CY2021	avco	Deferred Leasing Costs DeferredLeasingCosts	21203	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	45996	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-95133	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	331425	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1330890	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	79898	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	200477	usd
CY2022	avco	Increase Decrease Operating Lease IncreaseDecreaseOperatingLease	141556	usd
CY2021	avco	Increase Decrease Operating Lease IncreaseDecreaseOperatingLease	121020	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7037224	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5024479	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1749	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17502	usd
CY2021	us-gaap	Payments For Proceeds From Real Estate Partnership Investment Net PaymentsForProceedsFromRealEstatePartnershipInvestmentNet	10332	usd
CY2022	avco	Additional Investment In Equity Method Investment AdditionalInvestmentInEquityMethodInvestment	51999	usd
CY2021	avco	Additional Investment In Equity Method Investment AdditionalInvestmentInEquityMethodInvestment	40301	usd
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	8999722	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9053470	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-68135	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	390000	usd
CY2022	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	100000	usd
CY2021	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	2550262	usd
CY2022	us-gaap	Repayments Of Construction Loans Payable RepaymentsOfConstructionLoansPayable	410000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	3718943	usd
CY2022	avco	Proceeds From Issuance Of Balloon Promissory Note ProceedsFromIssuanceOfBalloonPromissoryNote	4800000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	266454	usd
CY2022	avco	Proceeds Received From Equity Offering ProceedsReceivedFromEquityOffering	735567	usd
CY2021	avco	Proceeds Received From Equity Offering ProceedsReceivedFromEquityOffering	2860304	usd
CY2022	avco	Disbursements For Equity Offering Costs DisbursementsForEquityOfferingCosts	24067	usd
CY2021	avco	Disbursements For Equity Offering Costs DisbursementsForEquityOfferingCosts	240434	usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	9000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17263989	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5170132	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10077	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3443	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1183372	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	80961	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	807538	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	726577	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1990910	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	807538	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	176000	usd
CY2021	avco	Common Stock Issued For Future Services CommonStockIssuedForFutureServices	155700	usd
CY2022	avco	Common Stock Issued For Accrued Liabilities CommonStockIssuedForAccruedLiabilities	30000	usd
CY2021	avco	Common Stock Issued For Accrued Liabilities CommonStockIssuedForAccruedLiabilities	276032	usd
CY2021	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	57599	usd
CY2021	avco	Accrued Professional Fees Relieved For Shares Issued AccruedProfessionalFeesRelievedForSharesIssued	202500	usd
CY2022	avco	Warrants Issued With Convertible Note Payable WarrantsIssuedWithConvertibleNotePayable	498509	usd
CY2022	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	2782569	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	4072958	usd
CY2022	avco	Reclassification Of Derivative Liability To Equity ReclassificationOfDerivativeLiabilityToEquity	2181820	usd
CY2022	avco	Related Party Loan And Accrued Interest Settled In Shares RelatedPartyLoanAndAccruedInterestSettledInShares	2888593	usd
CY2021	avco	Related Party Loan And Accrued Interest Settled In Shares RelatedPartyLoanAndAccruedInterestSettledInShares	3000000	usd
CY2016Q4	avco	Exchange For Common Stock ExchangeForCommonStock	50000000	shares
CY2022	avco	Percentage Of Capital Stock PercentageOfCapitalStock	1	pure
CY2022Q4	avco	Working Capital Deficit WorkingCapitalDeficit	1206279	usd
CY2022	avco	Negative Cash Flow From Operating Activities NegativeCashFlowFromOperatingActivities	11930847	usd
CY2021	avco	Negative Cash Flow From Operating Activities NegativeCashFlowFromOperatingActivities	-7037224	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Changes in these estimates and assumptions may have a material impact on the consolidated financial statements and accompanying notes. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Significant estimates during the years ended December 31, 2022 and 2021 include the useful life of property and equipment and investment in real estate, assumptions used in assessing impairment of long-term assets, valuation of deferred tax assets and the associated valuation allowances, valuation of stock-based compensation, and assumptions used to determine fair value of warrants and embedded conversion features of convertible note payable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b> </b></p>
CY2022Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	1990910	usd
CY2022Q4	avco	Cash Percentage CashPercentage	1	pure
CY2021Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	807538	usd
CY2021Q4	avco	Cash Percentage CashPercentage	1	pure
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	8999722	usd
CY2022	avco	Cash And Cash Equivalents Description CashAndCashEquivalentsDescription	Balances at state-owned banks within the PRC are covered by insurance up to RMB 500,000 (approximately $72,000) per bank. Any balance over RMB 500,000 per bank in PRC will not be covered.
CY2022Q4	avco	Cash And Due From Bank CashAndDueFromBank	1274920	cny
CY2022Q4	avco	Cash And Due From Bank CashAndDueFromBank	185000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	722573	cny
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	105000	usd
CY2022	avco	Federallyinsured Limits FederallyinsuredLimits	250000	usd
CY2022Q4	us-gaap	Cash Cash	4952000	usd
CY2022	avco	Deferred Financing Costs DeferredFinancingCosts	174107	usd
CY2021	avco	Deferred Financing Costs DeferredFinancingCosts	213279	usd
CY2022Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	34821	usd
CY2021Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	138	usd
CY2022Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	139286	usd
CY2021Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	74648	usd
CY2022Q4	us-gaap	Accumulated Amortization Of Current Deferred Finance Costs AccumulatedAmortizationOfCurrentDeferredFinanceCosts	236848	usd
CY2022Q4	us-gaap	Deferred Income DeferredIncome	27685	usd
CY2021Q4	us-gaap	Deferred Income DeferredIncome	8638	usd
CY2022	avco	Rent Receivable And Allowance For Doubtful Accounts RentReceivableAndAllowanceForDoubtfulAccounts	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>Revenue Recognition</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company recognizes revenue under Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of the revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Step 1: Identify the contract with the customer</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Step 2: Identify the performance obligations in the contract</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Step 3: Determine the transaction price</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Step 4: Allocate the transaction price to the performance obligations in the contract</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Step 5: Recognize revenue when the company satisfies a performance obligation</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>In order to identify the performance obligations in a contract with a customer, a company must assess the promised goods or services in the contract and identify each promised goods or service that is distinct. A performance obligation meets ASC 606’s defi<span style="font-family: Times New Roman, Times, Serif">nition of a “distinct” goods or service (or bundle of goods or services) if both of the following criteria are met:</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; width: 18pt"/><td style="font-family: Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif">●</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; ">The customer can benefit from the goods or service either on its own or together with other resources that are readily available to the customer (i.e., the goods or service is capable of being distinct).</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; width: 18pt"/><td style="font-family: Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif">●</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; ">The entity’s promise to transfer the goods or service to the customer is separately identifiable from other promises in the contract (i.e., the promise to transfer the goods or service is distinct within the context of the contract).</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; ">If a goods or service is not distinct, the goods or service is combined with other promised goods or services until a bundle of goods or services is identified that is distinct.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). The consideration promised in a contract with a customer may include fixed amounts, variable amounts, or both. Variable consideration is included in the transaction price only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The transaction price allocated to each performance obligation is recognized when that performance obligation is satisfied, at a point in time or over time as appropriate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company’s revenues are derived from providing medial related consulting services for its’ related parties. Revenues related to its service offerings are recognized at a point in time when service is rendered. Any payments received in advance of the performance of services are recorded as deferred revenue until such time as the services are performed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company has determined that the ASC 606 does not apply to rental contracts, which are within the scope of other revenue recognition accounting standards.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Rental income from operating leases is recognized on a straight-line basis under the guidance of ASC 842. Lease payments under tenant leases are recognized on a straight-line basis over the term of the related leases. The cumulative difference between lease revenue recognized under the straight-line method and contractual lease payments are included in rent receivable on the consolidated balance sheets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company does not offer promotional payments, customer coupons, rebates or other cash redemption offers to its customers.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	731328	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1025009	usd
CY2022Q4	us-gaap	Deferred Advertising Costs DeferredAdvertisingCosts	1325313	usd
CY2021Q4	us-gaap	Deferred Advertising Costs DeferredAdvertisingCosts	328565	usd
CY2022	us-gaap	Foreign Currency Translation Adjustment Description ForeignCurrencyTranslationAdjustmentDescription	Asset and liability accounts at December 31, 2022 and 2021 were translated at 6.8979 RMB and 6.3559 RMB to $1.00, respectively, which were the exchange rates on the balance sheet dates. Equity accounts were stated at their historical rates. The average translation rates applied to the statements of operations for the years ended December 31, 2022 and 2021 were 6.7309 RMB and 6.4515 RMB to $1.00, respectively.
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2454609	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
CY2022	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	6.5
CY2022	us-gaap	Reclassifications Reclassifications	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>Reclassification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications have no effect on the previously reported financial position, results of operations and cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Fiscal Period FiscalPeriod	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Fiscal Year End</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span>The Company has adopted a fiscal year end of December 31st.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b> </b></p>
CY2022	avco	Reverse Stock Split ReverseStockSplit	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>Reverse Stock Split</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; ">The Company effected a one-for-ten reverse stock split of its outstanding shares of common stock on January 5, 2023. The reverse split did not change the number of authorized shares of common stock or par value. All references in these consolidated financial statements to shares, share prices, exercise prices, and other per share information in all periods have been adjusted, on a retroactive basis, to reflect the reverse stock split.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p>
CY2022Q4	us-gaap	Prepaid Reinsurance Premiums PrepaidReinsurancePremiums	29301	usd
CY2021Q4	us-gaap	Prepaid Reinsurance Premiums PrepaidReinsurancePremiums	49656	usd
CY2022Q4	avco	Prepaid Professional Fees PrepaidProfessionalFees	93817	usd
CY2021Q4	avco	Prepaid Professional Fees PrepaidProfessionalFees	186609	usd
CY2022Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	174107	usd
CY2021Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	213279	usd
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	3531	usd
CY2021Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	23655	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	113916	usd
CY2021Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	141214	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	19084	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	20271	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Current DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent	20489	usd
CY2022Q4	avco	Longterm Straightline Rent Receivables LongtermStraightlineRentReceivables	144094	usd
CY2021Q4	avco	Longterm Straightline Rent Receivables LongtermStraightlineRentReceivables	163211	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	34034	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	18313	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	632373	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	816208	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	247990	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	448286	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	384383	usd
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	367922	usd
CY2022Q4	avco	Asset Noncurrent Total AssetNoncurrentTotal	632373	usd
CY2021Q4	avco	Asset Noncurrent Total AssetNoncurrentTotal	816208	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	409328	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	613600	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	271034	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	252053	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	138294	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	361547	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	162040	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	144513	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2987	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3276	usd
CY2022	avco	Other Operating Expense OtherOperatingExpense	825	usd
CY2021	avco	Other Operating Expense OtherOperatingExpense	19914	usd
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	158228	usd
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	121323	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	8237943	usd
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	8237943	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	877856	usd
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	709173	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	7360087	usd
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	7528770	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	168683	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	167248	usd
CY2022Q4	avco	Equity Method Investment EquityMethodInvestment	485008	usd
CY2021Q4	avco	Equity Method Investment EquityMethodInvestment	515632	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	41863	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	60463	usd
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	521758	usd
CY2021	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	40301	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	60463	usd
CY2021	avco	Foreign Currency Fluctuation Equity Method Investments ForeignCurrencyFluctuationEquityMethodInvestments	-14036	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	515632	usd
CY2022	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	51999	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	41863	usd
CY2022	avco	Foreign Currency Fluctuation Equity Method Investments ForeignCurrencyFluctuationEquityMethodInvestments	40760	usd
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3718943	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.5
CY2022Q2	us-gaap	Financing Interest Expense FinancingInterestExpense	2669522	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	485008	usd
CY2022Q4	avco	Equity Method Investment Summarized Financial Information Current Asset EquityMethodInvestmentSummarizedFinancialInformationCurrentAsset	1051	usd
CY2021Q4	avco	Equity Method Investment Summarized Financial Information Current Asset EquityMethodInvestmentSummarizedFinancialInformationCurrentAsset	5479	usd
CY2022Q4	avco	Equity Method Investment Summarized Financial Information Noncurrent Asset EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAsset	143984	usd
CY2021Q4	avco	Equity Method Investment Summarized Financial Information Noncurrent Asset EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAsset	216864	usd
CY2022Q4	avco	Equity Method Investment Summarized Financial Information Current Liabilitie EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilitie	43723	usd
CY2021Q4	avco	Equity Method Investment Summarized Financial Information Current Liabilitie EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilitie	56626	usd
CY2022Q4	avco	Equity Method Investment Summarized Financial Information Of Equity EquityMethodInvestmentSummarizedFinancialInformationOfEquity	101312	usd
CY2021Q4	avco	Equity Method Investment Summarized Financial Information Of Equity EquityMethodInvestmentSummarizedFinancialInformationOfEquity	165717	usd
CY2022	avco	Schedule Of Financial Information By Investee ScheduleOfFinancialInformationByInvestee	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net revenue</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Loss from operation</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">104,688</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">151,158</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">104,657</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">151,158</td><td style="text-align: left"> </td></tr> </table>
CY2022	avco	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Item EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItem	104688	usd
CY2021	avco	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Item EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItem	151158	usd
CY2022	avco	Equity Method Investment Summarized Financial Information Of Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationOfNetIncomeLoss	104657	usd
CY2021	avco	Equity Method Investment Summarized Financial Information Of Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationOfNetIncomeLoss	151158	usd
CY2022Q4	avco	Accrued Tenants Improvement Reimbursement AccruedTenantsImprovementReimbursement	43500	usd
CY2021Q4	avco	Accrued Tenants Improvement Reimbursement AccruedTenantsImprovementReimbursement	43500	usd
CY2022Q4	us-gaap	Deposits Deposits	73733	usd
CY2021Q4	us-gaap	Deposits Deposits	73733	usd
CY2022Q4	avco	Accrued Business Expense Reimbursement AccruedBusinessExpenseReimbursement	52437	usd
CY2021Q4	avco	Accrued Business Expense Reimbursement AccruedBusinessExpenseReimbursement	68172	usd
CY2022Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	15631	usd
CY2021Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	14372	usd
CY2022Q4	us-gaap	Deferred Income DeferredIncome	27685	usd
CY2021Q4	us-gaap	Deferred Income DeferredIncome	8638	usd
CY2022Q4	avco	Accrued Real Property Cleaning Service Fees AccruedRealPropertyCleaningServiceFees	23564	usd
CY2021Q4	avco	Accrued Real Property Cleaning Service Fees AccruedRealPropertyCleaningServiceFees	6600	usd
CY2021Q4	us-gaap	Other Ownership Interests Offering Costs OtherOwnershipInterestsOfferingCosts	40000	usd
CY2022Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	7337	usd
CY2021Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	14459	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	39347	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5846	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	283234	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	275320	usd
CY2022Q2	us-gaap	Financing Interest Expense FinancingInterestExpense	659581	usd
CY2022Q2	us-gaap	Financing Interest Expense FinancingInterestExpense	199840	usd
CY2022Q2	us-gaap	Financing Interest Expense FinancingInterestExpense	190000	usd
CY2022Q2	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	2669522	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	88984	shares
CY2022Q2	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	659581	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	21986	shares
CY2022Q2	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	199840	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6661	shares
CY2022Q2	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	190000	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6333	shares
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.01	pure
CY2022	avco	Debt Instrument Maturity Terms DebtInstrumentMaturityTerms	P10Y
CY2022	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.95	pure
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.75
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.0499	pure
CY2022Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	123964	shares
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	498509	usd
CY2022	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	2782569	usd
CY2022	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	3281078	usd
CY2022Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3718943	usd
CY2022Q3	avco	Unpaid Interest UnpaidInterest	9751	usd
CY2022Q3	us-gaap	Share Price SharePrice	6.5
CY2022Q3	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	344264	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3281078	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	9751	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	600749	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	4800000	usd
CY2022Q3	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.11	pure
CY2022Q3	us-gaap	Long Term Debt Contingent Payment Of Principal Or Interest LongTermDebtContingentPaymentOfPrincipalOrInterest	$44,000
CY2022Q4	us-gaap	Notes Payable NotesPayable	4563152	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	236848	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	29606	usd
CY2022	us-gaap	Interest Expense InterestExpense	176000	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	50400	usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	33600	usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	74100	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	33600	usd
CY2021	avco	Services Revenue ServicesRevenue	187412	usd
CY2021	us-gaap	Related Party Costs RelatedPartyCosts	187412	usd
CY2022	avco	Consulting Expenses ConsultingExpenses	144064	usd
CY2021	avco	Consulting Expenses ConsultingExpenses	216169	usd
CY2017	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	450000	usd
CY2022	avco	Principal Amount PrincipalAmount	0	usd
CY2021	avco	Principal Amount PrincipalAmount	390000	usd
CY2019Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-12-31
CY2020Q4	avco	Line Of Credits Facility Average Outstanding Amount LineOfCreditsFacilityAverageOutstandingAmount	3200000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2550262	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	3000000	usd
CY2021Q4	avco	Line Of Credits Facility Average Outstanding Amount LineOfCreditsFacilityAverageOutstandingAmount	2750262	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	100000	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	410000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2440262	usd
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	79898	usd
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	200477	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	0	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	368433	usd
CY2022Q3	avco	Sale Of Common Stock SaleOfCommonStock	44872	shares
CY2022Q3	avco	Purchase Price Per Share PurchasePricePerShare	7.8
CY2022Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	1000	usd
CY2022Q4	avco	Gross Proceeds GrossProceeds	4000000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.25	pure
CY2022Q4	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	2356797	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11567154	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-8504426	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-363693	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-586073	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11930847	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9090499	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1729700	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1810264	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-585627	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-612904	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	209806	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-152015	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2105521	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2575183	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-2105521	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-2575183	usd
CY2022	avco	Schedule Of Differences Between Us Statutory Rate And Companys Effective Tax Rate ScheduleOfDifferencesBetweenUSStatutoryRateAndCompanysEffectiveTaxRate	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">Years Ended December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">U.S. federal rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">U.S. state rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.6</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.7</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Permanent difference</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3.8</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Non-US rate differential</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.1</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">True ups</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5.3</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.9</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">U.S. valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17.6</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(32.9</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Total provision for income taxes</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">0.0</td><td style="padding-bottom: 4pt; text-align: left">%</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">0.0</td><td style="padding-bottom: 4pt; text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.056	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.067	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	-0.038	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.001	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.003	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.053	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.049	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.176	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.329	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3499969	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3696463	usd
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	103567	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	137864	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	47787	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	80816	usd
CY2022Q4	avco	Deferred Tax Accrued Settlement DeferredTaxAccruedSettlement	126495	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1687	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	23156	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	13634920	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11441503	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17448722	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15345505	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17329708	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15224188	usd
CY2022Q4	avco	Total Deferred Tax Assets Net TotalDeferredTaxAssetsNet	119014	usd
CY2021Q4	avco	Total Deferred Tax Assets Net TotalDeferredTaxAssetsNet	121317	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	119014	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	101534	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Regulatory Assets DeferredTaxLiabilitiesRegulatoryAssets	19783	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-119014	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-121317	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	46969776	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	38420422	usd
CY2022	avco	Net Operating Los Carry Forward Expiration Date NetOperatingLosCarryForwardExpirationDate	As of December 31, 2022, the Company has $44,482,221 of U.S. federal net operating loss carryovers that have no expiration date, and $2,487,555 of the federal net operating loss and state net operating loss carry-forwards begin to expire in 2034.
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	61847	usd
CY2022	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	10000	usd
CY2022	us-gaap	Other Information Pertaining To Income Taxes OtherInformationPertainingToIncomeTaxes	The Company has not been audited by any jurisdiction since its inception. The Company is open for audit by the U.S. Internal Revenue Service and U.S. state tax jurisdictions from 2019 to 2022, and open for audit by the Chinese Ministry of Finance from 2018 to 2022.
CY2022	avco	Designated Shares DesignatedShares	15000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	9	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.50	pure
CY2022	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.10	pure
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage	0.50	pure
CY2022	avco	Aggregate Share AggregateShare	9000	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	9000000	shares
CY2022	avco	Conversion Price Percentage ConversionPricePercentage	0.90	pure
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	44872	shares
CY2022Q3	avco	Purchase Price PurchasePrice	7.8
CY2022Q3	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	250000	usd
CY2022	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	40896	shares
CY2022	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	340950	usd
CY2022	avco	Shares Based Compensation SharesBasedCompensation	310950	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	30000	usd
CY2021	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	140568	shares
CY2021	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	1507488	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	276032	usd
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	155700	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	16736	shares
CY2021Q2	avco	Unpaid Professional Fees unpaidProfessionalFees	202500	usd
CY2021Q2	avco	Issuance Of Shares IssuanceOfShares	16736	shares
CY2021Q2	avco	Issuance Of Fair Value IssuanceOfFairValue	202500	usd
CY2022Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3718943	usd
CY2022Q3	avco	Unpaid Interest UnpaidInterest	9751	usd
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	573645	shares
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	6.5
CY2022Q3	avco	Conversion Agreement ConversionAgreement	344264	usd
CY2022Q3	avco	Debt Settlement Agreement Description DebtSettlementAgreementDescription	the Company and Mr. Lu entered into and closed a Debt Settlement Agreement and Release pursuant to which the Company settled $2,440,262 debt owed under the Line of Credit and unpaid interest of $448,331 by issuance of 444,399 shares of common stock of the Company (see Note 12 - Borrowings from Related Party – Line of Credit). The total amount of the debt settled of $2,888,593 exceeded the fair market value of the shares issued by $888,353 which was treated as a capital transaction due to Mr. Lu’s relationship with the Company.
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	3000000	usd
CY2021Q4	avco	Shares Of Common Stock SharesOfCommonStock	240000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Other Share Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease	240000	shares
CY2021Q4	avco	Fair Market Value FairMarketValue	3000000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	59000	usd
CY2022	avco	Stock Options Exercisable StockOptionsExercisable	40634	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	421428	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	726952	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	358113	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	769334	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	234856	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	84064	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	157207	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	123964	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.5
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	123964	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	12.5
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	12.5
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	123964	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M21D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	123964	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	12.5
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2022	avco	Statutory Reserve Percent StatutoryReservePercent	0.10	pure
CY2022	avco	Registered Capital Percentage RegisteredCapitalPercentage	0.50	pure
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Amount Available For Dividend Payments StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments	6578	usd
CY2021Q4	us-gaap	Statutory Accounting Practices Statutory Amount Available For Dividend Payments StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments	6578	usd
CY2022Q4	us-gaap	Other Restricted Assets OtherRestrictedAssets	1006578	usd
CY2021Q4	us-gaap	Other Restricted Assets OtherRestrictedAssets	706578	usd
CY2022Q4	avco	Net Assets Percentage NetAssetsPercentage	0.25	pure
CY2022Q4	srt	Financing Receivable Nonaccrual To Outstanding Percent FinancingReceivableNonaccrualToOutstandingPercent	0.814	pure
CY2021	avco	Concentration Risk Percentage ConcentrationRiskPercentage	0.806	pure
CY2022	us-gaap	Revenues Revenues	1202169	usd
CY2021	us-gaap	Revenues Revenues	1390972	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	929441	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	976454	usd
CY2022	us-gaap	Gross Profit GrossProfit	272728	usd
CY2021	us-gaap	Gross Profit GrossProfit	414518	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	9065623	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	9248348	usd
CY2022	avco	Interest Expens Related Party InterestExpensRelatedParty	3576333	usd
CY2021	avco	Interest Expens Related Party InterestExpensRelatedParty	200477	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	438381	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-56192	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-3137952	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-256669	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11930847	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9090499	usd
CY2022Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	7498381	usd
CY2021Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	7890317	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7498381	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7890317	usd
CY2017Q4	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	450000	usd
CY2022Q2	avco	Research Institute ResearchInstitute	450000	usd
CY2022Q4	avco	Issued And Outstanding Interest Percentage IssuedAndOutstandingInterestPercentage	0.60	pure
CY2022	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	900000	usd
CY2022	avco	Gain Loss On Condemnation Description GainLossOnCondemnationDescription	In addition, the Company agreed to pay the Research Institute 30% of the Company’s initial pre-tax profit of $3,333,333, 20% of the Company’s second pre-tax profit of $3,333,333 and 10% of the Company’s third pre-tax profit of $3,333,333. The parties provided a mutual release as well.
CY2022Q3	us-gaap-sup	Dividend Income Operating Paid In Cash DividendIncomeOperatingPaidInCash	450000	usd
CY2022Q3	us-gaap	Litigation Reserve LitigationReserve	900000	usd
CY2022	avco	Operating Leases Rent Expense OperatingLeasesRentExpense	141000	usd
CY2021	avco	Operating Leases Rent Expense OperatingLeasesRentExpense	143000	usd
CY2022	avco	Operating Cash Flow Paid For Operating Lease OperatingCashFlowPaidForOperatingLease	150577	usd
CY2021	avco	Operating Cash Flow Paid For Operating Lease OperatingCashFlowPaidForOperatingLease	130071	usd
CY2021	avco	Operating Lease OperatingLease	133879	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y1M28D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0488	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	11448	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11448	usd
CY2022Q4	avco	Amount Of Lease Payments Representing Interest AmountOfLeasePaymentsRepresentingInterest	-11	usd
CY2022Q4	avco	Operating Lease Liabilities OperatingLeaseLiabilities	11437	usd
CY2022	avco	Current Portion CurrentPortion	11437	usd
CY2022Q4	avco	Total Total	11437	usd
CY2018Q2	us-gaap	Investments And Cash InvestmentsAndCash	8000000	cny
CY2018Q2	us-gaap	Investments And Cash InvestmentsAndCash	1100000	usd
CY2022Q4	us-gaap	Investments And Cash InvestmentsAndCash	5110000	cny
CY2022Q4	us-gaap	Investments And Cash InvestmentsAndCash	700000	usd
CY2022	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	10000000	usd
CY2022	us-gaap	Noncash Contribution Expense NoncashContributionExpense	6660000	usd
CY2022	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	5000000	cny
CY2022	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	700000	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	300000	usd
CY2022	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	300000	usd
CY2022Q4	avco	Interest Purchase Agreement Description InterestPurchaseAgreementDescription	The consideration to be paid for the Purchased Interests consists of up to thirty-one million dollars ($31,000,000), of which (i) five million dollars ($5,000,000) was paid as a refundable prepayment at signing, (ii) ten million dollars ($10,000,000) will be paid in cash at the closing, (iii) fifteen million dollars ($15,000,000) will be paid pursuant to the issuance of 15,000 shares of the Company’s newly designated Series B Convertible Preferred Stock (the “Series B Preferred Stock”), stated value $1,000 (the “Series B Stated Value”), which Series B Preferred Stock will be convertible into shares of the Company’s common stock at a conversion price per share equal to $5.75 or an aggregate of 2,608,696 shares of the Company’s common stock, which are subject to the Lock Up Period and the restrictions on sale, and (iv) one million dollars ($1,000,000) will be paid on the first anniversary of the closing date (the “Anniversary Payment”). The Seller is also eligible to receive certain earnout payments upon achievement of certain operating results, which may be comprised of up to ten million dollars ($10,000,000) of which (x) five million dollars ($5,000,000) will be paid in cash and (y) five million dollars ($5,000,000) will be paid pursuant to the issuance of the number of shares of Company common stock valued at five million dollars ($5,000,000), calculated using the closing price of the Company’s common stock on December 31, 2023 (collectively, the “Earnout Payments”).
CY2022	avco	Interest Purchase Agreement Description InterestPurchaseAgreementDescription	The consideration paid by Buyer to Seller for the Purchased Interests consisted of $21,000,000, which comprised of (i) $9,000,000 in cash, (ii) $11,000,000 pursuant to the issuance of 11,000 shares of the Company’s newly designated Series B Convertible Preferred Stock (the “Series B Preferred Stock”), stated value $1,000 (the “Series B Stated Value”), and (iii) a $1,000,000 cash payment on February 9, 2024 (the “Anniversary Payment”). The Series B Preferred Stock will be convertible into shares of the Company’s common stock at a conversion price per share equal to $3.78 or an aggregate of 2,910,053 shares of the Company’s common stock and are subject to the Lock Up Period and the restrictions on sale. The Seller is also eligible, under the terms set forth in the Amended MIPA, to receive certain earnout payments upon achievement of certain operating results, which may be comprised of up to $10,000,000 of which (x) up to $5,000,000 will be paid in cash and (y) up to $5,000,000 will be paid pursuant to the issuance of the number of shares of Company common stock valued at $5,000,000, calculated using the closing price of the Company’s common stock on December 31, 2023, rounded down to the nearest whole share (collectively, the “Earnout Payments”).
CY2022Q4	us-gaap	Percentage Of Weighted Average Cost Inventory PercentageOfWeightedAverageCostInventory	0.20	pure
CY2022Q4	avco	Cash And Due Banks CashAndDueBanks	6000000	usd
CY2022	avco	Additional Shares AdditionalShares	4000	shares
CY2022Q4	avco	Preferred Stock Values PreferredStockValues	4000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	20000000	usd
CY2022Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.05	pure
CY2022	avco	Term Loan Payable TermLoanPayable	P3Y
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent		usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	avco	Preferred Stock Value1 PreferredStockValue1		usd
CY2021Q4	avco	Preferred Stock Value1 PreferredStockValue1		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2022	avco	Medical Related Consulting Services Related Party MedicalRelatedConsultingServicesRelatedParty		usd
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties		usd
CY2021	avco	Loss From Lawsuit LossFromLawsuit		usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2021	us-gaap	Other Expenses OtherExpenses		usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8491103	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9328609	shares
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
CY2021	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1		usd
CY2022	us-gaap	Payments For Proceeds From Real Estate Partnership Investment Net PaymentsForProceedsFromRealEstatePartnershipInvestmentNet		usd
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments		usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2021	us-gaap	Repayments Of Construction Loans Payable RepaymentsOfConstructionLoansPayable		usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2021	avco	Proceeds From Issuance Of Balloon Promissory Note ProceedsFromIssuanceOfBalloonPromissoryNote		usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2021	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	avco	Common Stock Issued For Future Services CommonStockIssuedForFutureServices		usd
CY2022	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
CY2022	avco	Accrued Professional Fees Relieved For Shares Issued AccruedProfessionalFeesRelievedForSharesIssued		usd
CY2021	avco	Warrants Issued With Convertible Note Payable WarrantsIssuedWithConvertibleNotePayable		usd
CY2021	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1		usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2021	avco	Reclassification Of Derivative Liability To Equity ReclassificationOfDerivativeLiabilityToEquity		usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash		usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Current DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent		usd
CY2022	avco	Equity Method Investment Summarized Financial Information Of Revenue EquityMethodInvestmentSummarizedFinancialInformationOfRevenue		usd
CY2021	avco	Equity Method Investment Summarized Financial Information Of Revenue EquityMethodInvestmentSummarizedFinancialInformationOfRevenue		usd
CY2022	avco	Equity Method Investment Summarized Financial Information Of Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationOfGrossProfitLoss		usd
CY2021	avco	Equity Method Investment Summarized Financial Information Of Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationOfGrossProfitLoss		usd
CY2022Q4	us-gaap	Other Ownership Interests Offering Costs OtherOwnershipInterestsOfferingCosts		usd
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2022	avco	Services Revenue ServicesRevenue		usd
CY2022	us-gaap	Related Party Costs RelatedPartyCosts		usd
CY2022Q4	avco	Line Of Credits Facility Average Outstanding Amount LineOfCreditsFacilityAverageOutstandingAmount		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Regulatory Assets DeferredTaxLiabilitiesRegulatoryAssets		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022	avco	Operating Lease OperatingLease		usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001630212
CY2022	dei	Entity Registrant Name EntityRegistrantName	AVALON GLOBOCARE CORP.

Files In Submission

Name	View Source	Status
avco-20221231_lab.xml	Edgar Link	unprocessable
0001213900-23-024687-index-headers.html	Edgar Link	pending
0001213900-23-024687-index.html	Edgar Link	pending
0001213900-23-024687.txt	Edgar Link	pending
0001213900-23-024687-xbrl.zip	Edgar Link	pending
avco-20221231.xsd	Edgar Link	pending
avco-20221231_cal.xml	Edgar Link	unprocessable
avco-20221231_def.xml	Edgar Link	unprocessable
f10k2022ex10-50_avalon.htm	Edgar Link	pending
f10k2022ex23-1_avalon.htm	Edgar Link	pending
f10k2022ex31-1_avalon.htm	Edgar Link	pending
f10k2022ex31-2_avalon.htm	Edgar Link	pending
f10k2022ex32-1_avalon.htm	Edgar Link	pending
f10k2022ex32-2_avalon.htm	Edgar Link	pending
f10k2022ex4-9_avalon.htm	Edgar Link	pending
f10k2022_avalonglob.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
avco-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10k2022_avalonglob_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALBT
Avalon Globocare Corp Stock $albt

2023 Q1 Form 10-K Financial Statement

#000121390023024687 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALBT Avalon Globocare Corp Stock $albt

2023 Q1 Form 10-K Financial Statement

#000121390023024687 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALBT
Avalon Globocare Corp Stock $albt